News and Announcements

RTW Biotech portfolio co Aktis Oncology raises $318m in IPO

By Frank Prenesti

Date: Monday 12 Jan 2026

(Sharecast News) - Life sciences investor RTW Biotech Opportunities said its private portfolio company Aktis Oncology had raised $318m via an IPO.
Aktis offered 17.65 million shares at $18 each, representing a 2.6% step-up from RTW Bio's prior holding value at November 30 and a18.3% step-up from the cost at the...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page